Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.
Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients. — المؤلف: Lavrov, Alexander V — BMC medical genomics 20200513
- المؤلف
- Lavrov, Alexander V
- النشر
- BMC medical genomics 20200513
- الوصف
- 37 p.
- الموضوعات
- Adult؛ Aged؛ Biomarkers, Tumor؛ Exome؛ Female؛ Genotype؛ Humans؛ Imatinib Mesylate